D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.9B |
| 2 |
Broadcom
AVGO
|
+$1.07B |
| 3 |
NVIDIA
NVDA
|
+$908M |
| 4 |
Meta Platforms (Facebook)
META
|
+$861M |
| 5 |
Intuitive Surgical
ISRG
|
+$666M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.68B |
| 2 |
Apple
AAPL
|
+$1.31B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$789M |
| 4 |
GE Aerospace
GE
|
+$653M |
| 5 |
Applovin
APP
|
+$634M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.25% |
| 2 | Consumer Discretionary | 7.51% |
| 3 | Financials | 7.11% |
| 4 | Healthcare | 6.95% |
| 5 | Industrials | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Apogee Therapeutics
APGE
$10.2B
| $4M | ﹤0.01% |
100,570
-93,958
| -48% | -$3.59M |
|
2302
CALL
Cytokinetics
CYTK
$10.9B
| $4M | ﹤0.01% |
72,700
-8,900
| -11% | -$367K |
|
2303
PUT
Best Buy
BBY
$18.5B
| $3.99M | ﹤0.01% |
52,700
+4,600
| +10% | +$330K |
|
2304
PUT
Tidewater
TDW
$3.65B
| $3.98M | ﹤0.01% |
74,700
| – | – |
|
|
GTM
2305
ZoomInfo Technologies
GTM
$978M
| $3.98M | ﹤0.01% |
364,565
-373,373
| -51% | -$4M |
|
2306
iShares US Medical Devices ETF
IHI
$3.14B
| $3.98M | ﹤0.01% |
+66,184
| New | +$4.05M |
|
2307
CALL
Suncor Energy
SU
$78.8B
| $3.97M | ﹤0.01% |
95,000
-450,000
| -83% | -$18.1M |
|
2308
PUT
Nu Holdings
NU
$70B
| $3.97M | ﹤0.01% |
248,000
-355,100
| -59% | -$4.95M |
|
2309
Employers Holdings
EIG
$941M
| $3.96M | ﹤0.01% |
93,331
-2,822
| -3% | -$123K |
|
|
SOBO
2310
PUT
South Bow Corp
SOBO
$7.81B
| $3.96M | ﹤0.01% |
140,000
| – | – |
|
2311
Vanguard Information Technology ETF
VGT
$139B
| $3.96M | ﹤0.01% |
42,392
-27,200
| -39% | -$2.38M |
|
2312
State Street SPDR S&P Retail ETF
XRT
$453M
| $3.94M | ﹤0.01% |
45,672
-18,325
| -29% | -$1.53M |
|
2313
PUT
Nutanix
NTNX
$16B
| $3.94M | ﹤0.01% |
52,900
-4,900
| -8% | -$360K |
|
2314
iShares US Home Construction ETF
ITB
$2.29B
| $3.93M | ﹤0.01% |
36,667
+11,803
| +47% | +$1.24M |
|
2315
Azenta
AZTA
$1.33B
| $3.93M | ﹤0.01% |
136,756
-51,352
| -27% | -$1.59M |
|
|
DEC
2316
Diversified Energy Company
DEC
$902M
| $3.93M | ﹤0.01% |
280,238
+221,031
| +373% | +$3.31M |
|
2317
CALL
Equinix
EQIX
$103B
| $3.92M | ﹤0.01% |
5,000
| – | – |
|
|
2318
PUT
Equinix
EQIX
$103B
| $3.92M | ﹤0.01% |
5,000
| – | – |
|
2319
Blackstone Secured Lending
BXSL
$5.39B
| $3.91M | ﹤0.01% |
150,036
+49,016
| +49% | +$1.47M |
|
|
MZTI
2320
The Marzetti Company
MZTI
$2.95B
| $3.91M | ﹤0.01% |
22,634
-2,384
| -10% | -$428K |
|
2321
PUT
Tyson Foods
TSN
$21.4B
| $3.91M | ﹤0.01% |
72,000
| – | – |
|
2322
PUT
Williams-Sonoma
WSM
$27.5B
| $3.91M | ﹤0.01% |
20,000
| – | – |
|
2323
CALL
MGM Resorts International
MGM
$11.7B
| $3.9M | ﹤0.01% |
+112,600
| New | +$4.13M |
|
|
SPR
2324
DELISTED
Spirit AeroSystems
SPR
| $3.9M | ﹤0.01% |
100,919
+73,718
| +271% | +$2.95M |
|
2325
Heron Therapeutics
HRTX
$94.1M
| $3.89M | ﹤0.01% |
3,088,492
-111,807
| -3% | -$177K |
|
Similar funds
D.E. Shaw & Co's Q3 2025 Portfolio in Review
As of Q3 2025, D.E. Shaw & Co held 5,023 positions worth $177B, up 26% from $141B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co deployed $15.2B of net new capital in Q3 2025, opening 714 new positions and adding to 1,743 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 3,319,000 shares worth $370M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.68B trimmed.
- D.E. Shaw & Co's largest Q3 2025 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 3,319,000 shares worth $370M.
- D.E. Shaw & Co added most to Microsoft in Q3 2025, an estimated $1.9B increase.
- D.E. Shaw & Co's biggest Q3 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.68B.
- D.E. Shaw & Co fully exited Hess in Q3 2025, selling an estimated $527M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $177B portfolio in Q3 2025.
- D.E. Shaw & Co opened 714 new positions and closed 514 in Q3 2025.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $177B.
Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.